TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
MedReleaf Corp.’s Q2 Results Weighed Down by Policy Changes and Rising Costs

Investing
Canopy Growth Corp.: Is This Stock Still Attractive?
Investing
What the Provincial vs. Federal Fight for Cannabis Taxes Means for Investors
Investing
Aurora Cannabis Inc. Rockets ~15% in a Day: Is it a Must-Buy Today?
Investing
Millennials: Buy and Hold These Marijuana Stocks Right Now

Investing
3 Reasons Canopy Growth Corp.’s Stock Could Triple!

Investing
Why Bruce Linton Deserves to Be CEO of the Year

Investing
A Detailed Look at My Top Stock Pick for November

Investing
Manitoba’s Plans for Marijuana Could Create Significant Growth Opportunities
Dividend Stocks
5 Non-Cannabis Stocks That Have High Growth and Pay Dividends

Investing
Reviewing My Pick of the Month for October
